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Platelet aggregation is an important factor contributing to the formation of thrombus due to an uncontrolled
blood clotting. An antiplatelet agent is a compound which decreases platelet aggregation and inhibits thrombus
formation. The objectives of this study were to determine the class of compound employing phytochemical assay
and to determine the in vitro antiplatelet activity of four fraction, namely hexane, ethyl acetate, butanol, and
water fractions of velvet bean seeds (Mucuna pruriens L.) using epinephrine (EPN) as agonist of platelet aggregation.
The antiplatelet activities were tested in human platelet rich plasma with hyperaggregation. To determine the
activities, EPN was arranged at 4 level of concentrations  (300, 150, 75, and 30 ì M), and antiplatelet agents were
at 500 µg/ml. The results indicated that ethyl acetate, butanol and water fraction contained high flavonoids and
moderate phenols. The water, butanol and ethyl acetate fractions of velvet bean seeds exhibited potential inhibition
of EPN-induced platelet aggregation at all concentrations. The strongest antiplatelet agent was water fraction
and had the same antiplatelet activity as aspirin at level 150, 75, and 30 ì M of EPN. Butanol fraction had the same
antiplatelet activity as aspirin at the lowest EPN (30 ì M).
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INTRODUCTION
Hyperaggregatebility is one of the risk factors in
pathogenesis of thrombosis and atherosclerosis, the most
common cause of premature death in developed world as
many as 30% of all deaths (Olas & Wachowicz 2005).
Platelets play a crucial role not only in homeostasis but
also in the development of cardiovascular disease (CVD).
The increasing acute clinical manifestations of coronary
atherosclerotic disease are caused by plaque disruption
and subsequent platelet-thrombus formation (O’Kennedy
et al. 2006). Inhibiting the platelet aggregation is one of
the efforts for preventing cardiovascular disease.
Atherosclerosis is the pathological consequence from the
modification of oxidized LDL in arterial wall which can be
stimulated by free radicals. Preventing the oxidation of
LDL has a meaning to prevent coronary heart disease.
Giving antioxidant supplement both vitamin E and
flavonoid (vegetable, fruit, tea) to CVD patients  increase
the defense towards the attack of free radicals (Olas &
Wachowicz 2005).
It has been found that platelet inhibitory drugs,
such as aspirin, physiologically reduce the incidence
of myocardial infarction, stroke, and death from
cardiovascular diseases in prevention trials. A number of
prospective randomized clinical trials have shown that
50-500 mg of aspirin per day reduces the risk of primary or
secondary cardiovascular events (Olas & Wachowicz
2005). The usage of aspirin has negative side effects: low
dose aspirin increases the risk of major bleeding and
intestinal ulceration, and for a prolong therapy, it usually
causes many side effect (Schror 1997; Ohmori et al. 2006).
The aspirin resistance is a clinical inability of aspirin to
protect individuals from arterial thrombotic events or when
laboratory methods indicate the failure of aspirin to inhibit
platelet activity (Cattaneo 2004; Ohmori et al. 2006). It is
estimated that between 8-45% of patients suffering an
ischemic stroke or cardiovascular disease are aspirin
resistant (McKee et al. 2002; Ohmori et al. 2006). It is an
urgent need to search natural compounds having
antiaggregation properties with minimal side effects and
safer. One of the natural compounds with antiplatelet
activity is flavonoid. It can prevent atherosclerosis,
endotelial damage, leukocyte activation, adhesive
aggregation, and platelet secretion (Koshy et al. 2001;
Bucki et al. 2003). Natural antioxidants having minimal
side effects can be obtained from plants containing
phenolic and polyphenolic compounds, such as
flavonoids (Bucki et al. 2003; Koleckar et al. 2008).
Flavonoids bioavailability and its relationship with
antioxidant and antiplatelet activity, resulting in
cardiovascular protection (Violi 2002).
The natural compounds including flavonoids can be
obtained ubiquitously in Indonesia, such as in velvet bean
Mucuna pruriens L., and it has not been used optimally.
Previous research demonstrated the total polyphenolic
content of the methanol extract of M. pruriens was
33.04 mg/g gallic acid, a noticeable amount of total phenols
(Rajeshwar et al. 2005). M. pruriens contains isoflavones
such as daidzin 0.041; glycitein 0.011; genistein 0.050;
aglucones total 0.131 mg/l (Handajani 2001). Methanol
extract of M. pruriens (MEMP) has high antioxidant
activity (Rajeshwar et al. 2005).
MATERIALS  AND  METHODS
The four fractions  (hexane, ethyl acetate, n-butanol,
and water fraction) were obtained from ethanol extract of
velvet bean seeds (M. pruriens L.).
The four fractions of velvet bean seeds were tested
by phytochemical assay including flavonoid assay,
phenolic, saponin, triterpenoid, steroid,  terpenoid, tanin,
and alkaloid assay. The four fractions and aspirin as
positive control were diluted with dimethyl sulfoxide
(DMSO 1%) achieving at level 500 ìg/ml. Epinephrine
(EPN) was diluted with distilled water at various
concentrations of 300, 150, 75, 30 ì M. Platelet rich plasma
(PRP) obtained from hyperaggregation individual (Helena
Laboratories 2008).
9 ml blood was collected from hyperaggregation
individual and added with 1 ml 3.8% sodium citrate as
anticoagulant. The blood was centrifuged at 100 x g  for
10 minutes. The platelet rich plasma (PRP) was removed
from the cells with a plastic pippete and placed in a plastic
tube. The PRP was maintained at room temperature for
30 minutes.  Platelet poor plasma (PPP) was prepared by
recentrifuging the remaining blood samples at 1600 x g for
10 minutes. PPP was then removed, placed in a plastic
tube, and the tube was maintained at room temperature
(Chun-Han et al. 1993; Helena Laboratories 2008).
Aggregation activity was measured by Platelet
Aggregation Chromogenic Kinetic System (PACKS-4).
450 ìl of PPP was pippeted into a cuvette. 450 ìl PRP and
40 ìl the antiplatelet agents (aspirin, hexan fraction, ethyl
acetate fraction, butanol fraction, water fraction) were also
pippeted into cuvettes with stir bar and incubated at 37 oC
for 3-5 minutes. The PPP and PRP cuvettes were inserted
into appropriate channels and the instrument was set up.
50 ìl of the aggregating reagent dilutions (Epinephrine)
at level 300, 150, 75, 30 ì M was added to the PRP cuvette
and the percent aggregation was recorded (Helena
Laboratories 2008).
All treatments consisted of 20 levels arranged in a
factorial design. The first factor was the inducing
concentration (four level concentrations) and the second
factor was the antiplatelet agent (five level antiplatelet
agents). The treatments were replicated three times. To
verify the statistical significance of the parameters, the
data was calculated for the values of means and standard
deviation (M + SD) and 95% confidence interval (CI) of
means. To compare several treatments, we used analysis
of variance (ANOVA) with two-factorial completely
randomized design. P-values of less than 0.05 were
considered as statiscally significant. Furthermore, to know
the difference of  means among treatments and to know
the best treatmet, we used Duncan’s Post-Hoc test 95%
confidence interval. Statistical analysis used SPSS 16.0
program.
RESULTS
The phytochemical assay showed that hexane fraction
of velvet bean seeds contained lowest flavonoids and
phenolics compound compared with the other fractions
(Table 1). Ethyl acetate, butanol and water fractions
contained high flavonoid and moderate phenolic
compounds, but they did not contain terpenoid and
triterpenoid compounds. Butanol fraction contained the
highest tanin compared with the other fractions. Water
fraction contained moderate alkaloids and butanol and
ethyl acetate fractions contained less alkaloids. Hexane,
ethyl acetate and butanol fractions conatained less
steroids. Butanol and water fractions contained less
saponins, whereas hexane and ethyl acetate fractions did
not contained saponins (Table 1).
Observing the antiplatelet activity, epinephrine (EPN)
agonist induced platelet aggregation at all level
concentrations, the lower concentration of EPN as agonist
caused the reduction of platelet aggregation (Table 2).
Aspirin as positive control decreased platelet aggregation
at all concentrations of EPN. After aspirin, the most
effective fraction showing the antiplatelet activity was
Table 1. The result of phytochemical assay of velvet bean seed fractions (hexane fraction, ethyl acetate, buthanol, and water fraction)
                                                                                                         Compound content
                            Tanins        Flavonoids        Phenols       Saponins        Terpenoids         Triterpenoids         Steroids        Alkaloids
Sample
(fractions)
Hexane
Ethylacetate
Buthanol
Water
-
++
+++
++
+
+++
+++
+++
+
++
++
++
-
-
+
+
+
-
-
-
-
-
-
-
+
+
+
-
-
+
+
++
+++: high content, ++: moderate content, +: less content, -: undetected.
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the water fraction followed by butanol fraction at all
concentrations of EPN, except at 30 mM of EPN. The
antiplatelet aggregation at 30 ì M concentration of EPN
showed similar activity among aspirin, water fraction and
butanol fraction of velvet bean (Table 2).
DISCUSSION
Previous research showed that velvet bean seeds are
rich in novel alkaloids, saponins, and sterols.  The seeds
of all Mucuna species contain a high concentration of
L-dopa; velvet bean seeds contain 7-10% L-dopa (Del
Carmen et al. 1999). Crude content of velvet bean showed
the presence of alkaloid, flavonoid, tannin, saponin,
quinone, and steroid/triterpenoid (Yulizia 2008).  The velvet
bean seeds contain the bioactive alkaloids mucunine,
mucunadine, mucuadinine, pruriendine and nicotine, ß-
sitosterol, glutathione, lecithin, oils, venolic and gallic
acids. The seeds with seed coat showed the presence of a
number of bioactive subtances including tryptamine,
alkylamines, steroids, flavonoids, coumarins,
cardenolides. The major phenolic constituent of Mucuna
beans was L-dopa (Rajeshwar et al. 2005). The phenolic
and flavonoid contents from our research verify the
previous research, but alkaloids, saponins, and sterols
concentration of Mucuna seeds can not be validated. The
different content of alkaloids and saponins may be caused
by different farming of strain of Mucuna.
Antiplatelet agents (aspirin and four fractions of velvet
bean) decreased the EPN-induced platelet aggregation
compared with control (hyperaggretation individual) at
all level concentration of epinephrine (Table 2). The
concentration level of EPN as an induceraffects the platelet
aggregation, the higher concentration of EPN the higher
the platelet aggregation (Hoffbrand & Pettit 1996). Blood
platelets can be activated by different compounds
including coagulation factors (thrombin), hormones
(epinephrine, vasopresin), low molecular weight
substances [serotonin, adenosine diphosphate (ADP),
lipid derivatives (platelet aggregating factor (PAF),
thromboxane A2 (TXA2)], and other protein substances
(collagen or immune complexes). The responses of platelet
include mainly adhesion (to foreign surfaces such as
collagen or glass), shape change, aggregation and
secretion of active compounds from three different storage
granules (dense granules, a-granules and lysosomes),
shedding of microvesicles, formation of platelet
procoagulant activity and retraction of fibrin clots
(Willoughby et al. 2002; Olas & Wachowicz 2005; Fogari
& Zoppi 2005). Epinephrine stimulates human blood
platelets by an á 2-adrenergic receptor mechanism
(Kjeldsen et al. 1995). á2-adrenergic receptors may more
directly activate phospholipase A2 via release of G protein
ßã-subunits. Phospholipase A2, which releases
arachidonic acid from platelet lipids to form thromboxane
A2 (TXA2), plays an important role in epinephrine-
mediated platelet activation (Kjeldsen et al. 1995).
Epinephrine agonists require aggregation for secretion to
occur. After platelet activation induced by an agonist,
intracellular signalling is necessary for cytoskeletal
reorganisation, fibrinogen receptor exposure (integrin
aIIbb3), and granule secretion to occur. Two differential
pathways central to platelet activation are the
phosphoinositide hydrolysis pathway and the eicosanoid
synthesis pathway (Olas & Wachowicz 2005). The
previous research showed that infused epinephrine in
doses of 0.1 and 0.2 µg/kg per minute on 40 healthy men
aged 20 to 40 years increased in the capacity for TXB2
production by platelets (Kjeldsen et al. 1995). Infused
epinephrine up to 0.04 µg/kg per minute in healthy men,
increased platelet count and size (Lande et al. 1988).
Epinephrine  in the presence of fibrinogen and Ca2+ (in
vitro) induces both primary and secondary aggregation,
potentiates aggregation (Kjeldsen et al. 1995).
Aspirin is the best antiplatelet agent at all level of
inducer concentrations and as an anti-thrombotic
compounds through the inhibition of platelet
cyclooxygenase-1 (COX-1) by irreversible acetylation of
a specific serine moiety, thereby blocking the formation
of thromboxane A2 (TXA2) for the lifetime of the platelets
(McKee et al. 2002; Ohmori et al. 2006).
Water fraction of velvet bean seeds is comparable to
aspirin because of the moderate  content of phenols and
the high content of flavonoids (Table 1). Phenols and
flavonoids show commonly high antioxidant and
antiplatelet activities. The previous research showed that
Table 2. The antiplatelet acitivity of velvet bean seed fractions
Antiplatelet agents                           EPN 300 ì M                     EPN 150 ì M                    EPN 75 ì M                       EPN 30 ì M
Control (Hyperaggregation)
Aspirin
Hexane fraction
Ethyl acetate fraction
Butanol fraction
Water fraction
82.633 + 8.228b
D
31.333 + 8.912a
A
68.233 + 9.127b
CD
69.733 + 5.064b
D
54.433 + 8.315b
B
47.600 + 8.0206b
B
74.067 + 3.761ab
C
28.600 + 4.029a
A
60.767 + 3.272ab
B
69.000 + 4.784b
C
54.367 + 2.318b
B
34.067 + 4.350a
A
68.267 + 9.215a
C
27.433 + 1.756a
A
55.033 + 4.168a
B
69.800 + 5.237b
C
51.033 + 10.934b
B
31.267 + 3.027a
A
66.067 + 2.732a
C
27.000 + 1.825a
A
53.933 + 4.509a
B
58.867 + 2.950a
B
31.133 + 3.134a
A
27.500 + 4.939a
A
The data showed means + standard deviation. The different small letters at the same row (among EPN concentrations) and capital
letters at the same column (among antiplatelet agents) show significant at the 5% (Duncan’s Post Hoc test).
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methanol extract of velvet bean seeds contained a
noticeable amount of total phenols (Rajeshwar et al. 2005).
Phenolic compounds exhibit a wide range of biological
effects, including antiplatelet, anti-inflammatory,
anticancer, antimutagenic, and antifungal properties. It is
also a potent antioxidant, reactive oxygen species
scavenger and metal chelators (Olas & Wachowicz 2005).
The extract contains many compounds including
flavonoids, tanins, phenols, saponins, terpenoids,
triterpenoids, steroids, alkaloids. Each fraction of velvet
bean contains different compounds (Table 1). This result
confirm the previous studiy that M. pruriens contained
isoflavones (the subclass of flavonoid) (Handajani 2001).
Eriodictyol and patuletin are flavonoids from Leuzea
carthamoides inhibiting platelet aggregation with agonist
collagen (COL) and arachidonic acid (AA) (Koleckar et
al.  2008).
Rutin is a flavonoid inhibiting platelet aggregation in
human platelets stimulated by COL agonist depend on its
concentration (250 and 290 µM) (Sheu et al. 2004). The
antiplatelet activity of rutin (flavonoid) may involve the
following pathways: rutin inhibits the activation of
phospholipase C, followed by inhibition of protein kinase
C activity and TXA2 formation, thereby leading to
inhibition of the phosphorylation of platelet protein of
M(r) 47000 (P47) a marker of protein kinase C activation
and intracellular Ca2+ mobilization, and finally resulting in
inhibition of platelet aggregation (Sheu et al. 2004). The
in vitro combination of 2 flavonoids, namely quercetin
and catechin, demonstrated that they are synergistic in
reducing platelet formation of H2O2 and inhibiting platelet
function by interfering the activation of phospholipase C
pathway (Violi 2002). Flavonoid bioavailability and its
relationship with antioxidant activity and platelet function
(Violi  2002). Flavonoids have antioxidant activity, inhibits
platelet aggregation and production of superoxide anion,
resulting in  cardiovascular protection (Violi 2002).
Catechin and eugenol (flavonoids) also inhibit
cyclooxygenase (COX) activities and platelet aggregation
(Huss et al. 2002). The isolation of flavonoids from
Cephalotaxus wilsoniana (Cephalotaxaceae) had
antiplatelet and anti-inflammatory effect (Wu et al. 2007).
The ginkgetin flavonoid was isolated from Cephalotaxus
wilsoniana and Justicia species had inhibitory effect on
cyclooxygenase-1 (COX-1). The flavonoids including
ginkgetin, taiwanhomoflavone C, justicidin B, and
justicidin D were isolated from Cephalotaxus wilsoniana
and Justicia showed inhibition of secondary aggregation
induced by adrenaline (Wu et al. 2007).
The butanol and water fractions of velvet bean seeds
show promising antiplatelet activities. These results
suggest that the antiplatelet activities of the fractions may
be mediated by TXA2 receptor blockade with TXA2
synthase inhibiting and suppressing cytosolic [Ca2+]
mobilization (Jin et al. 2005), and inhibiting the activation
of phospholipase C, followed by inhibition of protein
kinase C activity and TXA2 formation, thereby leading to
inhibition of the phosphorylation of P47 and intracellular
Ca2+  mobilization, finally resulting in inhibition of platelet
aggregation (Mc Kenzie 2004; Sheu et al. 2004). TXA2
formation cause the bond between platelets is weak and
platelet aggregation is reversible (primer aggregation),
secondary aggregation need longer time and produces
irreversible aggregation platelet (Mc Kenzie 2004).
Supplementation studies with polyphenol-rich foods or
extracts indicate that the compounds may exert effects in
vivo as well. For instance, the ingestion of dealcoholized
red wine, grape juice, or polyphenol extracts reduced
blood pressure and inhibited platelet aggregation in
laboratory animals (Erlund et al. 2008).
The flavonoid-rich beverages such as red wine and
purple grape juice are vasodilators and improve endothelial
function, probably because of a nitric oxide-dependent
mechanism  (Lin et al. 2007).
Quercetin and catechin are flavonoids antioxidant,
synergistically inhibit platelet function (in vitro assay)
by blunting the release of hydrogen peroxide (H2O2)  from
platelets, subsequently reducing phospholipase C
activation, calcium mobilization, and inositol phosphate
synthesis. Flavonoids inhibit platelet aggregation because
of their antioxidant activity, either by inhibiting the
formation of endogenous mediators derived from
phospholipid peroxidation, by blocking enzymatic free
radical production, or by reducing platelet sensitivity to
agonists by preventing lipid peroxidation (Murphy et al.
2003). Based on the experimental model of diabetes tested
animal, the combination of acetylsalicylic acid  and á-
tocopherol as antioxidant led to beneficial changes that
can help protect tissues from thrombotic incidents
(Gonzales-Correa et al. 2006). Various agonists may
stimulate platelet reactive oxygen pecies (ROS) production
and aggregation, by regulating AA metabolism or via COX
inhibition (Iuliano et al. 1997). In the presence of
haemoglobin, ROS-induced platelet aggregation is
enhanced (Iuliano et al. 1992). The resting platelets also
generated a low amount of ROS. AA stimulates platelet
ROS production, which is inhibited by hydroxychavicol
flavonoid (HC), supporting HC flavonoid as a ROS
scavenger (Chang et al. 2002). Our data (Table 2) showed
that water fraction, butanol and ethyl acetate fraction of
velvet bean seeds decreased platelet aggregation (as an
antiplatelet activity) probably due to antioxidant activities.
Previous research showed that M. pruriens had an ability
to scavenge DPPH radicals, ABTS radicals and ROS.
Velvet bean seeds significantly inhibit the oxidation of
lipids and deoxyribose sugar. M. pruriens exhibited
bivalent iron chelating activity (Dhanasekaran et al. 2008).
Methanol extract of M. pruriens shows strong antioxidant
activity by inhibiting DPPH and hydroxyl radicals, nitric
oxide and scavenging superoxide anion, scavenging
hydrogen peroxide, and reducing power activities when
compared with different standards such as BHT, L-
Ascorbic acid, curcumin, quercetin, and á-tocopherol
(Rajeshwar et al. 2005). AA-induced thromboxane
production or induced by the other agonists is not solely
mediated by ROS production. The other possible reason
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is that platelet ROS production can be mediated by COX
as well as other enzymes such as platelet isoforms of
NADPH oxidase, xanthine oxidase, mitochondrial
respiration (Krotz et al. 2002). HC flavonoid inhibits the
enzymes responsible for platelet ROS formation (Finazzi-
Agro et al. 1982; Chang et al. 2007).
Aspirin showed higher antiplatelet activity compared
with butanol and water fraction of velvet bean seeds,
particularly at high concentration of epinephrine. Because
aspirin is pure compound, it will produce high antiplatlet
activity. The butanol and water fractions of velvet bean
seeds contain complex compounds. To obtain the pure
compound with high antiplatelet activity  is required on
further study.
The ethyl acetate, butanol, and water fraction
contained high flavonoid and moderate phenol. The  water,
butanol, and ethyl acetate fraction of velvet bean seeds
exhibited potential inhibition of EPN induced platelet
aggregation at all concentrations. The strongest
antiplatelet was water fraction and had similar antiplatelet
activities with aspirin at level 150, 75, and 30 ì M of EPN
inducer. Butanol fraction had similar antiplatelet activity
with aspirin at lowest EPN inducer (30 ì M).
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